Dr. Yuval Rinkevich
Director, IRBM“Regenerative medicine encompasses our scientific desire to understand and capitalize on nature’s tools for healing. Our goal is to uncover novel tissue repair mechanisms that can be exploited to restore diseased and injured tissues..”
“Regenerative medicine encompasses our scientific desire to understand and capitalize on nature’s tools for healing. Our goal is to uncover novel tissue repair mechanisms that can be exploited to restore diseased and injured tissues.”
Academic Pathway & Research Area
Dr. Rinkevich has been working at the cutting edge of our understanding of tissue/organ repair and regeneration for over 20 years. His passion and commitment to understanding healing responses and tissue rejuvenation has led his career track from the point of obtaining his PhD degree from the Technion-Israel Institute of Technology, where he studied whole body regeneration from single blood vessels in Protochordates. Dr Rinkevich moved to Stanford University in the US where he investigated pivotal cellular lineages and stem cells in coordinating mammalian tissue repair and regeneration. His work at Stanford projected Dr Rinkevich into the forefront of the tissue repair field, uncovering the role of Engrailed-1 positive cells in the transition from scarless to scar forming tissue responses.
Today Dr Rinkevich is the Director of the Helmholtz Institute of Regenerative Biology and Medicine at the Helmholtz Center, Munich, Germany. His lab fuses a focus on basic biology, continuing to push forward our understanding of tissue/organ repair and regeneration, with a vision to applying these findings to drug development strategies and translation to the clinic. Publication in high impact journals including Nature and Science, numerous patents and supported by prestigious awards such as the ERC Consolidator Grant, highlight the quality of his team’s work. Dr Rinkevich’s latest work describing the role of fascia and transfer of extracellular matrix in tissue scarring and fibrosis in multiple organ systems is reinventing the way we look at tissue repair and regeneration. These findings provide a new perspective on the potential for clinical intervention, opening our minds to a revolution in antifibrotic therapy, a clinical area impacting fields of medicine from oncology to hepatology and pulmonology, and the potential to prevent and potentially resolve fibrotic disease.
Fields of Work and Expertise
Developmental Biology Stem Cell BiologyPathologyTissue Repair and Regeneration Fibrosis ScarringExtra-Cellular Matrix
Professional Background
Director, Institute of Regenerative Biology and Medicine
Tenured Principal Investigator / Helmholtz Zentrum München
PI, Helmholtz Center Munich
Basic Life Science Research Associate, Stanford University
Post doctorate, Stanford University
Doctorate in Biology (PhD), Israel Institute of Technology
Master of Science (MSc), Israel Institute of Technology
Bachelor of Science (BSc), Faculty of Life Sciences, Tel-Aviv University
Honors and Awards
2019-2024
ERC Consolidator grant award2017-2018
Early Career Investigator Fund/The Japan Agency for Medical Research and Development2017
Honored for outstanding scientific achievements/Helmholtz Zentrum München2016-2019
Career Development Award/Human Frontier Science Program (HFSP)2011-2015
Postdoctoral Fellowship/Thomas & Stacey Siebel Foundation2014
Travel award/2nd International Annual German Stem Cell Network (GSCN)2009-2012
Long-Term Fellowship/Human Frontier Science Program (HFSP).2008-2011
Postdoctoral Fellowship/Machiah Foundation, Jewish Community Foundation (JCF)2007
Travel award/4th International Tunicate meeting2006
Travel award/MGE Exploratory Workshop “Stem Cells in Marine Organisms”2006
Travel award/EMBO 3rd European conference on Regeneration2004
Student Fellowship/Friday Harbor Laboratories (FHL)